跳至主要内容
临床试验/ISRCTN72547749
ISRCTN72547749进行中(未招募)3 期

Perineural Local Anaesthetic Catheter aftEr Major lowEr limb amputatioN Trial (PLACEMENT)

Cardiff University0 个研究点目标入组 650 人开始时间: 2023年9月12日最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
650

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current participant inclusion criteria as of 02/07/2024:
  • 1. Aged 18 years or older
  • 2. Undergoing elective or emergency MLLA (BKA, TKA, or AKA) for complications of PAD, diabetes, or acute or chronic infection
  • 3. Able to assess pain using NRS
  • 4. Life expectancy of greater than two weeks
  • 5. (For people of childbearing potential) Willing to undergo a preoperative pregnancy test and agree to either use a highly effective method of contraception or abstain from sexual intercourse for 7 days after MLLA.
  • 6. (For male participants with female sexual partners who are considered to be of childbearing potential)* Willing to agree to use a condom or abstain from sexual intercourse for seven days after MLLA
  • Previous participant inclusion criteria:
  • 1. Aged 18 years or older
  • 2. Undergoing elective or emergency MLLA (BKA, TKA, or AKA) for complications of PAD and/or diabetes
  • 3. Able to assess pain using NRS
  • 4. Life expectancy of greater than two weeks
  • 5. (For people of childbearing potential) Willing to undergo a preoperative pregnancy test and agree to either use a highly effective method of contraception or abstain from sexual intercourse for 7 days after MLLA.
  • 6. (For male participants with female sexual partners who are considered to be of childbearing potential)* Willing to agree to use a condom or abstain from sexual intercourse for seven days after MLLA

排除标准

  • Current participant exclusion criteria as of 02/07/2024:
  • 1. Undergoing MLLA for trauma or cancer
  • 2. Undergoing digital, metatarsal, tarsal amputation, disarticulation of the hip or hindquarter amputation
  • 3. Undergoing simultaneous bilateral amputations
  • 4. Undergoing MLLA revision (excluding previous guillotine amputation)
  • 5. Allergy or intolerance to the PNC or local anaesthetic agents, or chronically taking class 1B anti-arrhythmic agents or local anaesthetic agents, for example in the form of transdermal patches.
  • 6. Expected to be sedated for more than 24 hours postoperatively
  • 7. Unable to provide consent due to incapacity (as defined by the Mental Capacity Act 2005)
  • 8. Vulnerable or protected adults.
  • 9. People who are currently pregnant or breastfeeding
  • 10. Previously enrolled in PLACEMENT (excluding PLACEMENT feasibility trial) for a prior MLLA
  • Previous participant exclusion criteria:
  • 1. Undergoing MLLA for trauma or cancer
  • 2. Undergoing digital, metatarsal, tarsal amputation, disarticulation of the hip or hindquarter amputation
  • 3. Undergoing simultaneous bilateral amputations
  • 4. Undergoing MLLA revision
  • 5. Allergy or intolerance to the PNC or local anaesthetic agents, or chronically taking class 1B anti-arrhythmic agents or local anaesthetic agents, for example in the form of transdermal patches.
  • 6. Expected to be sedated for more than 24 hours postoperatively
  • 7. Unable to provide consent due to incapacity (as defined by the Mental Capacity Act 2005)
  • 8. Vulnerable or protected adults.
  • 9. People who are currently pregnant or breastfeeding
  • 10. Previously enrolled in PLACEMENT (excluding PLACEMENT feasibility trial) for a prior MLLA

研究者

相似试验

进行中(未招募)
1 期
PERINEURAL LOCAL ANAESTHETIC CATHETER AFTER MAJOR LOWER LIMB AMPUTATION TRIAAnalgesia for lower limb amputation for peripheral vascular disease (PVD)MedDRA version: 19.1Level: SOCClassification code 10042613Term: Surgical and medical proceduresSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: SOCClassification code 10018065Term: General disorders and administration site conditionsSystem Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 19.1Level: SOCClassification code 10022117Term: Injury, poisoning and procedural complicationsSystem Organ Class: 10022117 - Injury, poisoning and procedural complications
EUCTR2016-003544-37-GBAneurin Bevan University Health Board50
进行中(未招募)
1 期
Comparison of different treatment modalities in peripheral nerve block catheter-based pain treatment after orthopaedic surgery.Postoperative pain, after orthopaedic surgery.MedDRA version: 20.0 Level: PT Classification code 10029173 Term: Nerve block System Organ Class: 10042613 - Surgical and medical procedures
EUCTR2017-002280-18-DKordsjællands Hospital Hillerød270
已完成
2 期
Perineural local anaesthetic catheter after major lower limb amputation feasibility trialMajor lower limb amputationCirculatory System
ISRCTN85710690Aneurin Bevan University Health Board50
进行中(未招募)
1 期
The use of a supraclavicular nerve catheter for local anesthetic block of the shoulder- an explorative study in healthy volunteers.MedDRA version: 19.1Level: LLTClassification code 10054711Term: Postoperative painSystem Organ Class: 100000004863
EUCTR2016-002835-14-DKordsjællands Hospital Hillerød
已完成
不适用
Continuous administration of local anesthetic for pain after amputation above kneePain after amputation above kneeSigns and Symptoms
ISRCTN45530042Helsinki University Hospital (Finland)180
Perineural local anaesthetic catheter after major... | 临床试验